[HTML][HTML] Complement, a target for therapy in inflammatory and degenerative diseases

BP Morgan, CL Harris - Nature reviews Drug discovery, 2015 - nature.com
The complement system is a key innate immune defence against infection and an important
driver of inflammation; however, these very properties can also cause harm. Inappropriate or …

Complement, inflammation and thrombosis

E Rawish, M Sauter, R Sauter… - British Journal of …, 2021 - Wiley Online Library
A mutual relationship exists between immune activation and mechanisms of thrombus
formation. In particular, elements of the innate immune response such as the complement …

Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study

S Deftereos, G Giannopoulos, C Angelidis… - Circulation, 2015 - Am Heart Assoc
Background—Inflammatory processes have been identified as key mediators of the
deleterious effects of ischemia/reperfusion in ST-segment–elevation myocardial infarction …

Platelets as therapeutic targets to prevent atherosclerosis

H Nording, L Baron, HF Langer - Atherosclerosis, 2020 - Elsevier
Cardiovascular disease remains the main cause of death worldwide. For this reason,
strategies for the primary prevention of atherosclerosis and atherosclerosis-related …

The complement system in human cardiometabolic disease

E Hertle, CDA Stehouwer… - Molecular immunology, 2014 - Elsevier
The complement system has been implicated in obesity, fatty liver, diabetes and
cardiovascular disease (CVD). Complement factors are produced in adipose tissue and …

Complement links platelets to innate immunity

H Nording, HF Langer - Seminars in immunology, 2018 - Elsevier
The complement system is a versatile part of our immune system. Various intersection points
of complement with other cells and molecules of the immune response are well described …

Targeting danger-associated molecular patterns after myocardial infarction

GPJ van Hout, F Arslan, G Pasterkamp… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Myocardial infarction (MI) provokes an intense inflammatory response that can
lead to left ventricular adverse remodeling and heart failure (HF). The prognosis of HF …

A vital role for complement in heart disease

KT Lappegård, P Garred, L Jonasson, T Espevik… - Molecular …, 2014 - Elsevier
Heart diseases are common and significant contributors to worldwide mortality and
morbidity. During recent years complement mediated inflammation has been shown to be an …

[HTML][HTML] Downregulation of the complement cascade in vitro, in mice and in patients with cardiovascular disease by the BET protein inhibitor apabetalone (RVX-208)

S Wasiak, D Gilham, LM Tsujikawa, C Halliday… - Journal of …, 2017 - Springer
Abstract Apabetalone (RVX-208) is an epigenetic regulator developed to treat
cardiovascular disease (CVD) that targets BET proteins. Through transcriptional regulation …

Inflammation and coagulation in atherosclerosis

KA Krychtiuk, SP Kastl, WS Speidl, J Wojta - Hämostaseologie, 2013 - thieme-connect.com
Cardiovascular diseases remain to be the leading cause of death in Western societies.
Despite major findings in vascular biology that lead to a better understanding of the …